相关实验视频

Updated: Jun 25, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

通过CRISPR-Cas13b媒介抑制HBV复制和蛋白质表达

Laura C McCoullough¹, Mohamed Fareh², Wenxin Hu²

¹Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia; Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Journal of hepatology

|May 30, 2024

概括

CRISPR-Cas13b有效向乙型肝炎病毒 (HBV) RNA,显著减少病毒复制和蛋白质表达. 这种新的方法显示出作为慢性HBV感染的新疗法具有前景.

科学领域:

分子生物学分子生物学
病毒学病毒学
基因编辑基因编辑

背景情况:

目前的乙型肝炎病毒 (HBV) 疗法在实现功能治愈方面存在局限性.
需要新的治疗点来解决HBV复制周期的多个阶段.
乙型肝炎病毒RNA是一个有希望的,但在很大程度上尚未开发的治疗点.

研究的目的:

调查CRISPR-Cas13b系统在向HBVRNA中的有效性.
评估CRISPR-Cas13b作为慢性HBV感染的新型抗病毒策略的潜力.

主要方法:

CRISPR-Cas13b CRISPR RNAs (crRNAs) 的设计是为了准HBV前基因组RNA的多个区域.
该系统在哺乳动物细胞,HBV感染模型和体内小鼠模型中进行了测试.
输送方法包括等离子体转染和脂质纳米粒子封装.

主要成果:

针对HBV的crRNAs在细胞培养中抑制HBV复制和蛋白质表达高达96%.
在体内,CRISPR-Cas13b可将乙型肝炎表面抗原 (HBsAg) 表达率降低50%.
脂质纳米颗粒的输送实现了87%的降低分泌的HBsAg.

结论:

可以编程CRISPR-Cas13b以专门降解HBVRNA,减少病毒复制和蛋白质表达.
这表明了CRISPR-Cas13b作为慢性HBV感染的新疗法潜力.

关键词:

克里斯普尔-Cas13是什么意思乙型肝炎病毒的感染.这是一个RNARNARNARNARNA.乙型肝炎表面抗原B型肝炎表面抗原

更多相关视频

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

相关概念视频

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...